Thursday, October 9, 2014

Gene Therapy - Table of Contents alert Volume 21 Issue 10

If you are unable to see the message below, click here to view.
Gene Therapy

TABLE OF CONTENTS

Volume 21, Issue 10 (October 2014)

In this issue
Original Articles
Short Communication

Also new
AOP
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement
Nature Communications soon to be fully open access
 
From 20th October Nature Communications, will become fully open access for all new submissions. If an author has a manuscript they wish to submit to the journal via the subscription route, they must submit before 20th October. After this date all new submissions, if accepted, will be published open access and an article processing charge (APC) will apply. For any questions on the switch, open access or advice on policies and funding, visit our website, read the press release or contact our dedicated support team at openaccess@nature.com.

Original Articles

Top

Retinal transduction profiles by high-capacity viral vectors

A Puppo, G Cesi, E Marrocco, P Piccolo, S Jacca, D M Shayakhmetov, R J Parks, B L Davidson, S Colloca, N Brunetti-Pierri, P Ng, G Donofrio and A Auricchio

Gene Ther 2014 21: 855-865; advance online publication, July 3, 2014; 10.1038/gt.2014.57

Abstract | Full Text

AdLTR2EF1α-FGF2-mediated prevention of fractionated irradiation-induced salivary hypofunction in swine

L Guo, R Gao, J Xu, L Jin, A P Cotrim, X Yan, C Zheng, C M Goldsmith, Z Shan, B Hai, J Zhou, C Zhang, B J Baum and S Wang

Gene Ther 2014 21: 866-873; advance online publication, July 17, 2014; 10.1038/gt.2014.63

Abstract | Full Text

Long-term efficiency of mesenchymal stromal cell-mediated CD-MSC/5FC therapy in human melanoma xenograft model

L Kucerova, S Skolekova, L Demkova, R Bohovic and M Matuskova

Gene Ther 2014 21: 874-887; advance online publication, July 24, 2014; 10.1038/gt.2014.66

Abstract | Full Text

DNA vaccine elicits an efficient antitumor response by targeting the mutant Kras in a transgenic mouse lung cancer model

T-Y Weng, M-C Yen, C-T Huang, J-J Hung, Y-L Chen, W-C Chen, C-Y Wang, J-Y Chang and M-D Lai

Gene Ther 2014 21: 888-896; advance online publication, July 31, 2014; 10.1038/gt.2014.67

Abstract | Full Text

A dual-reporter, diagnostic vector for prostate cancer detection and tumor imaging

J R Richter, M Mahoney, J M Warram, S Samuel and K R Zinn

Gene Ther 2014 21: 897-902; advance online publication, July 24, 2014; 10.1038/gt.2014.68

Abstract | Full Text

Re-engineered p53 activates apoptosis in vivo and causes primary tumor regression in a dominant negative breast cancer xenograft model

A Okal, K J Matissek, S J Matissek, R Price, M E Salama, M M Janát-Amsbury and C S Lim

Gene Ther 2014 21: 903-912; advance online publication, July 31, 2014; 10.1038/gt.2014.70

Abstract | Full Text

Short Communication

Top

Differential targeting of feline photoreceptors by recombinant adeno-associated viral vectors: implications for preclinical gene therapy trials

A L Minella, F M Mowat, K L Willett, D Sledge, J T Bartoe, J Bennett and S M Petersen-Jones

Gene Ther 2014 21: 913-920; advance online publication, July 24, 2014; 10.1038/gt.2014.65

Abstract | Full Text

Advertisement
Scientific Data will be attending the American Society of Human Genetics conference on 19th - 21st October. Come and visit us at the Nature booth #1321-1323 to learn more.
 
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Gene Therapy. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: